证券代码：688265 证券简称：南模生物 公告编号：2026-002 上海南方模式生物科技股份有限公司 2026年第一次临时股东会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的 真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 本次会议是否有被否决议案：无 一、会议召开和出席情况 （三）出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及其持有表决权数量的情 况： 表决情况： ■ （四）表决方式是否符合《公司法》及公司章程的规定，股东会主持情况等。 本次股东会由公司董事会召集，董事长费俭先生主持，采取现场投票和网络投票相结合的表决方式。本 次会议的召集、召开程序均符合《公司法》《公司章程》及《公司股东会议事规则》的规定。 （五）公司董事和董事会秘书的列席情况 1、公司在任董事11人，列席11人； 2、董事会秘书杨雪女士列席了会议；其他高级管理人员列席了会议。 二、议案审议情况 （一）非累积投票议案 审议结果：通过 1、议案名称：关于参与投资策源一期基金暨关联交易的议案 ■ 1、本次股东会见证的律师事务所：北京市通商律师事务所 律师： ...

一、 会议召开和出席情况 （一） 股东会召开的时间：2026 年 1 月 16 日 证券代码：688265 证券简称：南模生物 公告编号：2026-002 上海南方模式生物科技股份有限公司 2026年第一次临时股东会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次会议是否有被否决议案：无 （二） 股东会召开的地点：上海市浦东新区琥珀路 63 弄 1 号 M10 会议室 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 53 | | --- | --- | | 普通股股东人数 | 53 | | 2、出席会议的股东所持有的表决权数量 | 28,496,788 | | 普通股股东所持有表决权数量 | 28,496,788 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 37.6856 | | 例（%） | | | 普通股股东所持有表决权数量占公司表决权数量的比例（%） | 37.6856 | （ ...

中国北京市建国门外大街 1 号国贸写字楼 2 座 12-15 层 100004 12-15th Floor, China World Office 2, No. 1 Jianguomenwai Avenue, Beijing 100004, China 电话 Tel: +86 10 6563 7181 传真 Fax: +86 10 6569 3838 电邮 Email: beijing@tongshang.com 网址 Web: www.tongshang.com 北京市通商律师事务所 关于上海南方模式生物科技股份有限公司 2026 年第一次临时股东会的法律意见书 致：上海南方模式生物科技股份有限公司 根据《中华人民共和国公司法》《中华人民共和国证券法》《上市公司股 东会规则》（以下简称"《股东会规则》"）《律师事务所证券法律业务执业 规则（试行）》等法律、法规及规范性文件和《上海南方模式生物科技股份有 限公司章程》（以下简称"《公司章程》"）的相关规定，北京市通商律师事 务所（以下简称"本所"）接受上海南方模式生物科技股份有限公司（以下简 称"公司"）委托，指派律师出席了公司于 2026 年 1 月 16 ...

Group 1 - The core point of the news is that Nanmo Biotechnology experienced a decline of 5.82% in its stock price, reaching 51.80 yuan per share, with a trading volume of 30.42 million yuan and a turnover rate of 0.74%, resulting in a total market capitalization of 4.039 billion yuan [1] - Nanmo Biotechnology, established on September 20, 2000, and listed on December 28, 2021, specializes in the research, production, sales, and related technical services of genetically modified animal models [1] - The revenue composition of Nanmo Biotechnology includes standardized models (48.34%), model technical services (21.92%), model breeding (19.50%), customized models (9.34%), and other supplementary services (0.91%) [1] Group 2 - Tianhong Fund's Tianhong Medical Health A (001558) has entered the top ten circulating shareholders of Nanmo Biotechnology, holding 377,400 shares, which accounts for 0.48% of the circulating shares, with an estimated floating loss of approximately 1.2078 million yuan [2] - Tianhong Medical Health A was established on June 30, 2015, with a latest scale of 263 million yuan, achieving a year-to-date return of 16.59% and a one-year return of 56.11% [2] - The fund manager of Tianhong Medical Health A is Lü Qiao, who has a total fund asset scale of 506 million yuan, with the best fund return during the tenure being 48.08% and the worst being 47.47% [3]

Core Viewpoint - Recently, Zichuang Guangke (Meishan) Smart Energy Technology Co., Ltd. was established, focusing on the renewable energy sector with a registered capital of 100 million RMB [1] Company Information - The legal representative of the newly established company is Ding Lizhong [1] - The company is wholly owned by Shenzhen Ziguang Lighting Technology Co., Ltd. [1] Business Scope - The business scope includes manufacturing and sales of renewable energy power equipment, engineering and technical research and experimental development, leasing of photovoltaic power generation equipment, sales of photovoltaic equipment and components, and solar power technology services [1]

1月14日，南模生物涨6.19%，截至发稿，报52.50元/股，成交5298.52万元，换手率1.36%，总市值40.93 亿元。南模生物股价已经连续5天上涨，区间累计涨幅13.26%。 截至发稿，吕俏累计任职时间1年13天，现任基金资产总规模5.06亿元，任职期间最佳基金回报 48.08%， 任职期间最差基金回报47.47%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 责任编辑：小浪快报 数据显示，天弘基金旗下1只基金位居南模生物十大流通股东。天弘医疗健康A（001558）三季度新进 十大流通股东，持有股数37.74万股，占流通股的比例为0.48%。根据测算，今日浮盈赚取约115.49万 元。连续5天上涨期间浮盈赚取218.53万元。 天弘医疗健康A（001558）成立日期2015年6月30日，最新规模2.63亿。今年以来收益14.09%，同类排 名261/8838；近一年收益55.87%，同类排名1806/8089；成立以来收益87.12%。 天弘医疗健康A（0 ...

南模生物1月12日大宗交易平台出现一笔成交，成交量28.10万股，成交金额1514.59万元，大宗交易成交 价为53.90元，相对今日收盘价溢价13.95%。该笔交易的买方营业部为国泰海通证券股份有限公司上海 静安区南京西路证券营业部，卖方营业部为中银国际证券股份有限公司上海虹口区东长治路证券营业 部。 进一步统计，近3个月内该股累计发生2笔大宗交易，合计成交金额为1814.50万元。 证券时报·数据宝统计显示，南模生物今日收盘价为47.30元，上涨0.92%，日换手率为2.06%，成交额为 7461.82万元，全天主力资金净流入430.06万元，近5日该股累计上涨7.65%，近5日资金合计净流入 2184.63万元。 两融数据显示，该股最新融资余额为8306.52万元，近5日增加2171.70万元，增幅为35.40%。 据天眼查APP显示，上海南方模式生物科技股份有限公司成立于2000年09月20日，注册资本7796.3513 万人民币。（数据宝） 1月12日南模生物大宗交易一览 | 成交量 | 成交金 | 成交价 | 相对当日收 | | | | --- | --- | --- | --- | --- | ...

Core Viewpoint - On January 12, 16 stocks from the STAR Market experienced block trading, with a total transaction value of 825 million yuan, indicating active trading in the sector [1]. Group 1: Trading Overview - A total of 47 block trades were recorded, with a cumulative trading volume of 15.24 million shares [1]. - The stock with the highest transaction value was Zhongwei Company, which had 10 block trades totaling 895,000 shares and a transaction value of 287 million yuan [1]. - Other notable stocks in terms of transaction value included Hu Silicon Industry and Tuo Jing Technology, with transaction amounts of 154 million yuan and 149 million yuan, respectively [1]. Group 2: Price Premium/Discount Analysis - Among the stocks that underwent block trading, the highest discount rates relative to the closing price were observed in Kangxi Communication, Laplace, and Foxit Software, with discount rates of 26.01%, 23.06%, and 19.99% respectively [1]. - Conversely, the stock with the highest premium was Nanmo Biological, which had a premium rate of 13.95% [1]. Group 3: Stock Performance - The STAR 50 Index rose by 2.43% on the same day, with 447 stocks (74.50%) in the STAR Market experiencing price increases [1]. - The average increase for stocks involved in block trading was 2.83%, with Foxit Software, Kangxi Communication, and Xidi Micro leading the gains at 20.00%, 8.09%, and 5.05% respectively [1]. - Stocks that saw the largest declines included Liyang Chip, Huahai Chengke, and Tuo Jing Technology, with decreases of 2.42%, 2.04%, and 0.77% respectively [1]. Group 4: Institutional Participation - Out of the block trades, 12 transactions involved institutional buyers or sellers, covering 5 stocks [2]. - The stocks with the highest institutional buying amounts were Zhongwei Company, Yunlu Co., and Chuangyao Technology, with respective amounts of 161 million yuan, 5.51 million yuan, and 5.08 million yuan [2]. - In terms of capital flow, 5 stocks experienced net inflows, with Zhongwei Company, Foxit Software, and Xidi Micro leading the inflows at 133 million yuan, 89.49 million yuan, and 21.57 million yuan respectively [2].

| 交易日期 | 证券简称 | 证券代码 | 成交价(元) 成交金额(万元) 成交量( * ) 买入营业部 | | | | 卖出营业部 | | --- | --- | --- | --- | --- | --- | --- | --- | | 2026-01-12 | 南模生物 | 688265 | 53.9 28.1 | 1514.59 | 国泰海通证券股份 有限公司上海静安 区南京两路：专题 | 中银国际证券股份 有限公司上海虹口 区东长治路 | | 1月12日，南模生物大宗交易成交28.1万股，成交额1514.59万元，占当日总成交额的16.87%，成交价53.9元，较市场收盘价47.3元溢价13.95%。 ...

分组1 - China Merchants Bank plans to distribute a cash dividend of approximately 25.548 billion yuan for the first half of 2025, with a per-share dividend of 1.013 yuan (tax included) [1] - Luzhou Laojiao proposes a cash dividend of 13.58 yuan per 10 shares, totaling around 2 billion yuan (tax included) for the mid-2025 profit distribution [3] - Tongfu Microelectronics intends to raise up to 4.4 billion yuan through a private placement to enhance its packaging capacity for storage chips and other emerging applications [2] 分组2 - Xibu Gold announces that its shareholder, Turpan Jinyuan Mining Co., plans to reduce its stake by up to 1% due to funding needs [4] - Jiaoyun Co. is planning a significant asset restructuring by swapping its automotive sales and service assets with the cultural and tourism-related assets of its controlling shareholder [5] - Guo Sheng Technology expects a negative net profit for the fiscal year 2025, leading to a stock resumption after a period of trading suspension [8] 分组3 - North Rare Earth adjusts its first-quarter rare earth concentrate trading price to 26,834 yuan per ton, reflecting a 2.4% increase from the previous quarter [11] - Baotou Steel plans to set the same trading price for rare earth concentrate at 26,834 yuan per ton for the first quarter of 2026, also indicating a 2.4% increase [12] - Wanbangde's subsidiary has been selected for a national major science and technology project for Alzheimer's drug development, which is expected to positively impact its clinical development and long-term business growth [13]